This is far too preliminary to justify such a surge in stock price. The headline says it all: it “COULD” protect against variants, but that's far from guaranteed. It's only in phase 1. It has phase 2 and phase 3 to hurdle before it can even be sold.

Did you not see that she sold the bulk of her $BIDU holdings today? This is poorly timed advice.

“$HGEN made its stock market debut on September 18, 2020 through a public offering of eight million shares”. The uplist to NASDAQ happened not its “stock market debut”. Does that mean that $OCGN has yet to make its “stock market debut”?

People won’t realize that this is a 3rd party article, if it was me, I’d pull it rather than risk the reputational damage. StockNews.com clearly does not have the same editorial standards or quality that TalkMarkets does.

Very impressive. It's hard to find such detailed information about this company.

You need to wait for the leg to drop out of the rectangle to confirm the bear flag formation. All you have right now is consolidation since there's been no break-out.

Great article @[David Merkel](user:5064), congrats on the Editor's Choice selection.

Well said, Wall Street Bets was right that $GME was worth more than the street believed, but once it rose so much... well there is no point in buying an over valued stock.

This article is a rear-view mirror assessment. If your buying #NOK, it’s a bet on the 1-3 year period ahead and for that, I think there’s a compelling bull case, especially given current value. I also think that very soon, the share price will begin with a “5”.

I believe some of the author's statements are inaccurate.

Excellent analysis.